H

Hunan Nucien Pharmaceutical Co Ltd
SSE:688189

Watchlist Manager
Hunan Nucien Pharmaceutical Co Ltd
SSE:688189
Watchlist
Price: 8.7 CNY 0.35% Market Closed
Market Cap: 2.4B CNY

Wall Street
Price Targets

Price Targets Summary
Hunan Nucien Pharmaceutical Co Ltd

There are no price targets for Hunan Nucien Pharmaceutical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Hunan Nucien Pharmaceutical Co Ltd Competitors:
Price Targets

Revenue
Forecast

-15% / Year
Past Growth
38% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
-15% / Year
Past Growth
38% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 6 years the compound annual growth rate for Hunan Nucien Pharmaceutical Co Ltd's revenue is -15%. The projected CAGR for the next 3 years is 38%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Operating Income forecast
is not available for
Hunan Nucien Pharmaceutical Co Ltd

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Hunan Nucien Pharmaceutical Co Ltd's stock price target?
Not Available

Hunan Nucien Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Hunan Nucien Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
38%

For the last 6 years the compound annual growth rate for Hunan Nucien Pharmaceutical Co Ltd's revenue is -15%. The projected CAGR for the next 3 years is 38%.

Back to Top